An interventional study of Osteopathic Manipulative Treatment (OMT) in Pelvic Floor Disfunction, sponsored by Elizabeth Perrero. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-23.
Sponsored by Elizabeth Perrero · Not applicable, Interventional, and Treatment
This study will examine whether osteopathic manipulative treatment (OMT) affects pelvic floor symptoms, physical activity, and running gait in female runners. Participants will complete six study sessions over 6 to 8 weeks that include questionnaires, gait assessments, and OMT. Participants will also use wearable devices to track physical activity throughout the study.
Exclusion Criteria:
Participants will receive OMT to address somatic dysfunction identified during the osteopathic structural examination. All participants will receive the intervention over six treatment sessions during six to eight weeks.
Procedure: Osteopathic Manipulative Treatment (OMT)
OMT will be provided to treat somatic dysfunction identified during the osteopathic structural examination.
Change in Pelvic Floor Dysfunction Symptoms
Pelvic floor symptoms will be assessed using the Female Genitourinary Pain Index (Modified NIH Chronic Prostatitis Symptom Index for Women).
Time frame: Baseline to End of Study (6-8 Weeks)
Total Training Load
Total training load will be assessed using Training Stress Score from the provided wearable device. Training Stress Score is a numeric value combine workout duration and intensity, with higher scores indicating greater training load and lower score indicating less training load.
Time frame: Baseline to End of Study (6-8 Weeks)
Running Volume
Running volume will be assessed using data from the provided wearable device. The unit of measure for this outcome is miles.
Time frame: Baseline to End of Study (6-8 Weeks)
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.